Heart attack

March 30, 2018

Managing heart diseases with essential amino acids:  Essential amino acid-based therapy for Cardiomyopathy: A therapeutic mix encompassing essential amino acids (10g) decreases the expression of Sox6, restores the balance between slow- and fast-twitch myofiber proteins and alleviates Cardiomyopathy via up regulation of its target gene, 31/March/2018, 12.01 am

Introduction: What they say   A study from the Department of Cardiology, Boston Children’s Hospital, Harvard Medical School, Boston, Massachusetts, USA; and Harvard Stem Cell Institute, Harvard University, Cambridge, Massachusetts, USA shows that “Trbp regulates heart […]
March 30, 2018

A sweet way to protect your heart: Trisaccharide-based therapy for Myocardial Infarction: Raffinose, a trisaccharide composed of galactose, glucose, and fructose, inhibits DNA damage responses, induces telomerase expression, inhibits telomere shortening, and promotes cardiomyocyte survival after myocardial infarction, via up regulation of PNUTS, 30/March/2018, 10.54 pm

What they say:  A recent study from the Institute for Cardiovascular Regeneration, Centre of Molecular Medicine, Frankfurt, Germany shows that “MicroRNA-34a regulates cardiac ageing and function.” This study was published, in the 7 March  2013 issue of of […]
March 29, 2018

A noble way to keep cardiac diseases at bay: Noble gas xenon-based cardiac rejuvenation therapy: Inhalation of Xenon gas suppresses tumor suppressor INK4a/p16 expression, and inhibits dilated cardiomyopathy via up regulation of its target gene, 29/March/2018, 6.31 am

What we say: Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: A noble way to keep cardiac diseases at bay: Noble gas xenon-based cardiac […]
March 29, 2018

A noble way to say no to cardiac diseases: Noble gas Xenon-based therapy for attenuating pathogenesis-associated with Myocardial infarction: Inhalation of noble gas Xenon decreases IRF3 (Interferon regulatory transcription factor-3), GM-CSF (Granulocyte-macrophage colony-stimulating factor) and GRK2(G protein-coupled receptor kinase) expression, inhibits undue leucocyte activation and invasion, suppresses recruitment of inflammatory cells, inhibits ventricular dilation, and promotes heart repair and survival, via up regulation of its target gene, 29/March/2018, 5.50 am

Introduction: What they say: A recent study from Department of Systems Biology, Harvard Medical School, Boston, Massachusetts, USA; and Cardiovascular Research Center, Massachusetts General Hospital and […]